Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Anagenics ( (AU:AN1) ) just unveiled an announcement.
Anagenics Limited reported a significant decrease in revenue and net loss for the financial year ending June 30, 2025. Revenue from ordinary activities fell by 52.6% to $5.1 million, while the net loss after tax attributable to shareholders decreased by 83.5% to $1.2 million. No dividends were declared, and there was no change in control of subsidiaries. The net tangible asset backing per ordinary security dropped to -0.03 cents from 0.09 cents in the previous year. The financial statements were audited and received an unmodified report.
More about Anagenics
Current Market Cap: A$2.98M
For an in-depth examination of AN1 stock, go to TipRanks’ Overview page.